Stero Biotechs

Stero Biotechs is a dynamic clinical-stage research and development company dedicated to pioneering CBD-based solutions aimed at reducing the side effects and the necessity of steroid therapy. Located at 14 Baruch Hirsh St, Bnei Brak, Israel 5120206, IL, Stero Biotechs is committed to enhancing patient outcomes through innovative pharmaceutical advancements.

With a broad intellectual property portfolio, Stero Biotechs is actively engaged in multiple clinical trials, including Phase 2a trials for Crohn's disease and Chronic Urticaria, as well as a Phase 1/2 trial for treating severe COVID-19 patients. These trials are covered by Stero Biotechs' extensive IP and are pursuing the FDA drug route, showcasing the company's dedication to rigorous scientific research and regulatory compliance. Stero Biotechs strives to improve the quality of life for millions by developing groundbreaking treatments.

Stero Biotechs is poised for continued growth and impact in the biotechnology sector. We invite the management team at Stero Biotechs to create a customized and exclusive company showcase and product listing on our platform, highlighting your contributions to the field.